Bahrain approves Valneva’s COVID vaccine for emergency use
Valneva expects to deliver the first shipments of its VLA2001 vaccine to the kingdom at the end of March
Bahrain has granted Emergency Use Authorisation (EUA) to the COVID-19 vaccine developed by France’s Valneva, the company said in a statement recently.
Valneva expects to deliver the first shipments of its VLA2001 vaccine to the kingdom at the end of March.